A Mini-Review Regarding the Carcinogenesis and Morphology of Serous Tumors of the Ovary, Fallopian Tube and Peritoneum
Abstract
:Introduction
Discussions
Benign serous tumors of the ovary and fallopian tube
Serous borderline tumors of the ovary and fallopian tubes
The serous borderline tumor of the peritoneum
Low-grade serous carcinomas of the ovary and fallopian tubes
High-grade serous carcinomas of the ovary and fallopian tubes
Serous carcinomas of the peritoneum
Conclusions
Conflicts of Interest disclosure
Compliance with ethical standards
References
- Seidman, J.D.; Mehrotra, A. Benign ovarian serous tumors: Are-evaluation and proposed reclassification of serous “cystadenomas” and “cystadenofibromas”. Gynecol Oncol. 2005, 96, 395–401. [Google Scholar] [CrossRef]
- Grigoriu, C.; Constantin, A.E.; Munteanu, D.; et al. Chronic pelvic pain-diagnostic and therapeutic updates. Conference: 17th National Congress of the Romanian- Society-of-Obstetrics-and-Gynecology/Ist Advanced Colposcopy Course. In Proceedings of SOGR 2018: The 17th National Congress of the Romanian Society of Obstetrics and Gynecology & First Advanced Colposcopy Course, Iaşi, Romania, 19–22 September 2018; pp. 373–376, ISBN 978-88-85813-33-5. [Google Scholar]
- Ionescu, C.A.; Matei, A.; Navolan, D.; Dimitriu, M.; Bohâltea, R.; Neacsu, A.; Ilinca, C.; Ples, L. Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses. Medicine 2018, 97, e11762. [Google Scholar] [CrossRef]
- Bohilțea, R.; Turcan, G.; Cîrstoiu, M.M.; Ionescu, C.; Nemescu, D.; Turcan, N.; Vladareanu, R. Clinical Implementation of Ultrasound Gynecological Examination Report (software REGU) Based on International Consensuses of Tumor Study Groups. In Proceedings of the 5th Romanian Congress of the Romanian Society of Ultrasound in Obstetrics and Gynecology, Targu Mures, Romania, 20–22 April 2017; pp. 99–104, ISBN 978-88-95922-88-1. [Google Scholar]
- Czernobilsky, B.; Borenstein, R.; Lancet, M. Cystadenofibroma of the ovary. A clinicopathologic study of 34 cases and comparison with serous cystadenoma. Cancer 1974, 34, 1971–1981. [Google Scholar] [CrossRef] [PubMed]
- Shah, R.; Shah, V.; McCluggage, W.G. Ovarian serous cystadenofibroma with signet ring-stromal cells: Report of 2 cases. Int J Gynecol Pathol. 2010, 29, 411–414. [Google Scholar] [CrossRef] [PubMed]
- Dillon, K.; Boyde, A.; Murphy, J.K.; McCluggage, W.G. Ovarian serous cystadenofibroma with stromal sex cord elements: Report of a unique case. Int J Gynecol Pathol. 2006, 25, 336–339. [Google Scholar] [CrossRef] [PubMed]
- Hunter, S.M.; Anglesio, M.S.; Sharma, R.; Gilks, C.B.; Melnyk, N.; Chiew, Y.E.; deFazio, A.; Australian Ovarian Cancer Study Group; Longacre, T.A.; Huntsman, D.G.; et al. Copy number aberrations in benign serous ovarian tumors: A case for reclassification? Clin Cancer Res. 2011, 17, 7273–7282. [Google Scholar] [CrossRef]
- Munteanu, O.; Voicu, D.; Voiculescu, D.I.; Negreanu, L.; Georgescu, T.A.; Sajin, M.; Berceanu, C.; Mehedinţu, C.; Brătilă, E.; Istrate-Ofiţeru, A.M.; et al. Colon cancer in pregnancy: A diagnostic and therapeutic challenge. Rom J Morphol Embryol. 2019, 60, 307–317. [Google Scholar]
- Deavers, M.T.; Gershenson, D.M.; Tortolero-Luna, G.; Malpica, A.; Lu, K.H.; Silva, E.G. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: A study of 99 advanced stage cases. Am J Surg Pathol. 2002, 26, 1129–1141. [Google Scholar] [CrossRef]
- Vang, R.; Hannibal, C.G.; Junge, J.; Frederiksen, K.; Kjaer, S.K.; Kurman, R.J. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. Am J Surg Pathol. 2017, 41, 725–737. [Google Scholar] [CrossRef]
- Burks, R.T.; Sherman, M.E.; Kurman, R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996, 20, 1319–1330. [Google Scholar] [CrossRef]
- Bohîlțea, R.E.; Bacalbaşa, N.; et al. Bilateral serous surface papillary borderline ovarian tumor in 19-year-old patient. Ultrasound, immunohistochemical and therapeutic particularities of reproductive age. Rom J Morphol Embryol. 2017, 58, 989–995. [Google Scholar]
- Rasmussen, E.L.K.; Hannibal, C.G.; Dehlendorff, C.; Baandrup, L.; Junge, J.; Vang, R.; Kurman, R.J.; Kjaer, S.K. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study. Gynecol Oncol. 2017, 144, 571–576. [Google Scholar] [CrossRef]
- Hannibal, C.G.; Vang, R.; Junge, J.; Frederiksen, K.; Kurman, R.J.; Kjaer, S.K. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma. Gynecol Oncol. 2017, 144, 174–180. [Google Scholar] [CrossRef]
- Quddus, M.R.; Rashid, L.B.; Hansen, K.; Sung, C.J.; Lawrence, W.D. High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman. Histopathology. 2009, 54, 771–773. [Google Scholar] [CrossRef] [PubMed]
- Prade, M.; Spatz, A.; Bentley, R.; Duvillard, P.; Bognel, C.; Robboy, S.J. Borderline and malignant serous tumor arising in pelvic lymph nodes: Evidence of origin in benign glandular inclusions. Int J Gynecol Pathol. 1995, 14, 87–91. [Google Scholar] [CrossRef] [PubMed]
- Dehari, R.; Kurman, R.J.; Logani, S.; Shih, I.e.M. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: A morphologic and molecular genetic analysis. Am J Surg Pathol. 2007, 31, 1007–1012. [Google Scholar] [CrossRef] [PubMed]
- Katabuchi, H.; Tashiro, H.; Cho, K.R.; Kurman, R.J.; Hedrick Ellenson, L. Micropapillary serous carcinoma of the ovary: An immunohistochemical and mutational analysis of p53. Int J Gynecol Pathol. 1998, 17, 54–60. [Google Scholar] [CrossRef]
- Darai, E.; Walker-Combrouze, F.; Mlika-Cabanne, N.; Feldmann, G.; Madelenat, P.; Scoazec, J.Y. Expression of p53 protein in borderline epithelial ovarian tumors: A clinicopathologic study of 39 cases. Eur J Gynaecol Oncol. 1998, 19, 144–149. [Google Scholar]
- Garg, K.; Park, K.J.; Soslow, R.A. Low-grade serous neoplasms of the ovary with transformation to high- grade carcinomas: A report of 3 cases. Int J Gynecol Pathol. 2012, 31, 423–428. [Google Scholar] [CrossRef]
- Bell, K.A.; Smith Sehdev, A.E.; Kurman, R.J. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001, 25, 419–432. [Google Scholar] [CrossRef]
- Djordjevic, B.; Malpica, A. Lymph node involvement in ovarian serous tumors of low malignant potential: A clinicopathologic study of thirty-six cases. Am J Surg Pathol. 2010, 34, 1–9. [Google Scholar] [CrossRef]
- Laury, A.R.; Hornick, J.L.; Perets, R.; Krane, J.F.; Corson, J.; Drapkin, R.; Hirsch, M.S. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010, 34, 627–635. [Google Scholar] [CrossRef]
- O'Neill, C.J.; McBride, H.A.; Connolly, L.E.; Deavers, M.T.; Malpica, A.; McCluggage, W.G. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour. Histopathology 2007, 50, 773–779. [Google Scholar] [CrossRef] [PubMed]
- Badea, M.; Baros, A.; Bohiltea, R.E.; Julea, I.E.; Furtunescu, F.L.; Istrate-Ofiteru, A.M.; Iovan, L.; Cirstoiu, M.M.; Burcin, M.R.; Turcan, N.; et al. Modern interdisciplinary monitoring of cervical cancer risk. Rom J Morphol Embryol. 2019, 60, 469–478. [Google Scholar]
- Xing, D.; Suryo Rahmanto, Y.; Zeppernick, F.; Hannibal, C.G.; Kjaer, S.K.; Vang, R.; Shih, I.M.; Wang, T.L. Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma. Hum Pathol 2017, 68, 87–91. [Google Scholar] [CrossRef]
- Ardighieri, L.; Zeppernick, F.; Hannibal, C.G.; Vang, R.; Cope, L.; Junge, J.; Kjaer, S.K.; Kurman, R.J.; Shih, I.e.M. Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants. J Pathol. 2014, 232, 16–22. [Google Scholar] [CrossRef]
- Zeppernick, F.; Ardighieri, L.; Hannibal, C.G.; Vang, R.; Junge, J.; Kjaer, S.K.; Zhang, R.; Kurman, R.J.; Shih, I.e.M. BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors. Am J Surg Pathol. 2014, 38, 1603–1611. [Google Scholar] [CrossRef] [PubMed]
- Longacre, T.A.; McKenney, J.K.; Tazelaar, H.D.; Kempson, R.L.; Hendrickson, M.R. Ovarian serous tumors of low malignant potential (borderline tumors): Outcome- based study of 276 patients with long-term (> or =5- year) follow-up. Am J Surg Pathol. 2005, 29, 707–723. [Google Scholar] [CrossRef] [PubMed]
- Bohilțea, R.; Turcan, N.; Bratu, O.; Navolan, D.; Ducu, I.; Cîrstoiu, M. Genetic Mechanisms in Endometriosis. In Proceedings of the SOGR 2018. The 17th National Congress of The Romanian Society of Obstetrics and Gynecology, Iaşi, Romania, 19–22 September 2018; pp. 713–718, ISBN 978-88-85813-33-5. [Google Scholar]
- Georgescu, T.A.; Oproiu, A.M.; Rădăşan, M.G.; Dumitru, A.V.; Costache, D.; Pătraşcu, O.M.; Lăzăroiu, A.M.; Chefani, A.E.; Sajin, M.; Costache, M. Keratoacanthoma centrifugum marginatum: An unusual clinical and histopathological diagnostic pitfall. Rom J Morphol Embryol. 2017, 58, 561–565. [Google Scholar]
- McKenney, J.K.; Gilks, C.B.; Kalloger, S.; Longacre, T.A. Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome. Am J Surg Pathol. 2016, 40, 1155–1164. [Google Scholar] [CrossRef]
- Hutton, R.L.; Dalton, S.R. Primary peritoneal serous borderline tumors. Arch Pathol Lab Med. 2007, 131, 138–144. [Google Scholar] [CrossRef] [PubMed]
- Bell, D.A.; Scully, R.E. Serous borderline tumors of the peritoneum. Am J Surg Pathol. 1990, 14, 230–239. [Google Scholar] [CrossRef]
- Georgescu, T.A.; Dumitru, A.V.; Oproiu, A.M.; Nica, A.E.; Costache, D.; Pătraşcu, O.M.; Lăzăroiu, A.M.; Chefani, A.E.; Sajin, M.; Costache, M. Cutaneous microcystic/reticular schwannoma: Case report and literature review of an exceedingly rare entity with an unusual presentation. Rom J Morphol Embryol. 2018, 59, 303–309. [Google Scholar]
- Malpica, A.; Longacre, T.A. Prognostic indicators in ovarian serous borderline tumours. Pathology. 2018, 50, 205–213. [Google Scholar] [CrossRef]
- Tsang, Y.T.; Deavers, M.T.; Sun, C.C.; Kwan, S.Y.; Kuo, E.; Malpica, A.; Mok, S.C.; Gershenson, D.M.; Wong, K.K. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low- grade serous carcinoma. J Pathol. 2013, 231, 449–456. [Google Scholar] [CrossRef] [PubMed]
- Ahn, G.; Folkins, A.K.; McKenney, J.K.; Longacre, T.A. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion. Am J Surg Pathol. 2016, 40, 1165–1176. [Google Scholar] [CrossRef]
- Okoye, E.; Euscher, E.D.; Malpica, A. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution. Am J Surg Pathol. 2016, 40, 627–635. [Google Scholar] [CrossRef]
- May, T.; Shoni, M.; Crum, C.P.; Xian, W.; Vathipadiekal, V.; Birrer, M.; Rosen, B.; Tone, A.; Murphy, K.J. Low-grade and high-grade serous Mullerian carcinoma: Review and analysis of publicly available gene expression profiles. Gynecol Oncol. 2013, 128, 488–492. [Google Scholar] [CrossRef]
- Escobar, J.; Klimowicz, A.C.; Dean, M.; Chu, P.; Nation, J.G.; Nelson, G.S.; Ghatage, P.; Kalloger, S.E.; Köbel, M. Quantification of ER/PR expression in ovarian low- grade serous carcinoma. Gynecol Oncol. 2013, 128, 371–376. [Google Scholar] [CrossRef]
- Yemelyanova, A.; Vang, R.; Kshirsagar, M.; Lu, D.; Marks, M.A.; Shih, I.e.M.; Kurman, R.J. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: An immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011, 24, 1248–1253. [Google Scholar] [CrossRef]
- Etemadmoghadam, D.; Azar, W.J.; Lei, Y.; Moujaber, T.; Garsed, D.W.; Kennedy, C.J.; Fereday, S.; Mitchell, C.; Chiew, Y.E.; Hendley, J.; et al. EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas. Cancer Res. 2017, 77, 4268–4278. [Google Scholar] [CrossRef]
- McIntyre, J.B.; Rambau, P.F.; Chan, A.; Yap, S.; Morris, D.; Nelson, G.S.; Köbel, M. Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma. Histopathology. 2017, 70, 347–358. [Google Scholar] [CrossRef]
- Xing, D.; Suryo Rahmanto, Y.; Zeppernick, F.; Hannibal, C.G.; Kjaer, S.K.; Vang, R.; Shih, I.M.; Wang, T.L. Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma. Hum Pathol 2017, 68, 87–91. [Google Scholar] [CrossRef]
- Labidi-Galy, S.I.; Papp, E.; Hallberg, D.; Niknafs, N.; Adleff, V.; et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017, 8, 1093. [Google Scholar] [CrossRef]
- McCluggage, W.G.; Hirschowitz, L.; Gilks, C.B.; Wilkinson, N.; Singh, N. The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians. Int J Gynecol Pathol. 2017, 36, 230–239. [Google Scholar] [CrossRef]
- Singh, N.; Benson, J.L.; Gan, C.; Anglesio, M.; Arora, R.; Faruqi, A.Z.; Hirschowitz, L.; Kommoss, F.; Scott, K.; Trevisan, G.; et al. Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage. Int J Gynecol Pathol. 2018, 37, 324–330. [Google Scholar] [CrossRef]
- Singh, N.; McCluggage, W.G.; Gilks, C.B. High-grade serous carcinoma of tubo-ovarian origin: Recent developments. Histopathology. 2017, 71, 339–356. [Google Scholar] [CrossRef]
- Stewart, C.J.R.; Stewart, L.M.; Holman, C.D.J.; Jordan, S.; Semmens, J.; Spilsbury, K.; Threlfall, T. Value of Pathology Review in a Population-based Series of Ovarian Tumors. Int J Gynecol Pathol. 2017, 36, 377–385. [Google Scholar] [CrossRef]
- Kurman, R.J.; Shih, I.e.M. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol. 2016, 186, 733–747. [Google Scholar] [CrossRef]
- Balalau, C.; Voiculescu, S.; Motofei, I.; Scaunasu, R.V.; Negrei, C. Low dose tamoxifen as treatment of benign breast proliferative lesions. Farmacia. 2015, 63, 371–375. [Google Scholar]
- Rekhi, B.; Deodhar, K.K.; Menon, S.; Maheshwari, A.; Bajpai, J.; Ghosh, J.; Shylasree, S.T.; Gupta, S. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high- grade serous carcinoma. APMIS. 2018, 126, 45–55. [Google Scholar] [CrossRef]
- Mazilu, L.; Stanculeanu, D.L.; Gheorghe, A.D.; Voinea, F.; Suceveanu, A.P.; Pituru, S.; Diaconu, C.C.; Parepa, I.R.; Stoian, A.P.; Pop, C.S.; et al. Incidence of chemotherapy-induced peripheral neuropathy in cancer patients in clinical practice. Farmacia. 2019, 67, 472–476. [Google Scholar] [CrossRef]
- Casey, L.; Köbel, M.; Ganesan, R.; Tam, S.; Prasad, R.; Böhm, S.; Lockley, M.; Jeyarajah, A.J.; Brockbank, E.; Faruqi, A.; et al. A comparison of p53 and WT1 immunohistochemical expression patterns in tubo- ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy. Histopathology. 2017, 71, 736–742. [Google Scholar] [CrossRef]
- Turcan, N.; Bohiltea, R.E.; Ionita-Radu, F.; Furtunescu, F.; Navolan, D.; Berceanu, C.; Nemescu, D.; Cirstoiu, M.M. Unfavorable influence of prematurity on the neonatal prognostic of small for gestational age fetuses. Exp. Ther. Med. 2020, 20, 2415–2422. [Google Scholar] [CrossRef]
- Bohîlțea, R.; Furtunescu, F.; Turcan, N.; Navolan, D.; Ducu, I.; Cîrstoiu, M. Prematurity and Intrauterine Growth Restriction: Comparative Analysis of Incidence and Short Term Complication. In Proceedings of the SOGR 2018. The 17th National Congress of The Romanian Society of Obstetrics and Gynecology, Iaşi, Romania, 19–22 September 2018; pp. 708–712. [Google Scholar]
- Mihai, D.; Comandasu, D.; Mitran, M.; Bohîlțea, R.; Brătilă, E. The Evolution and Prognosis of Fetal Ovarian Cysts. Our Clinical Experience and Review of the Literature. In Proceedings of the 5th Romanian Congress of the Romanian Society of Ultrasound in Obstetrics and Gynecology, Targu Mures, Romania, 20–22 April 2017; pp. 378–384, ISBN 978-88-95922-88-1. [Google Scholar]
- Herghelegiu, C.G.; Neacşu, A.; Oprescu, N.D.; Cărbunaru, A.E.; Brăila, A.D.; Curea, F.G.; Marcu, M.L.; Ioan, R.G.; Bohîlţea, R.E. Difficulties of clinical and histopathological diagnosis in advanced vulvar clear cell carcinoma. Rom J Morphol Embryol. 2018, 59, 1233–1237. [Google Scholar]
- Geicu, O.I.; Stanca, L.; Voicu, S.N.; Dinischiotu, A.; Bilteanu, L.; Serban, A.I.; Calu, V. Dietary AGEs involvement in colonic inflammation and cancer: Insights from an in vitro enterocyte model. Sci Rep. 2020, 10, 2754. [Google Scholar] [CrossRef]
© 2021 by the author. 2021 Tiberiu-Augustin Georgescu, Roxana Bohiltea, Octavian Munteanu, Corina Grigoriu, Ioana Paunica, Maria Sajin
Share and Cite
Georgescu, T.-A.; Bohiltea, R.; Munteanu, O.; Grigoriu, C.; Paunica, I.; Sajin, M. A Mini-Review Regarding the Carcinogenesis and Morphology of Serous Tumors of the Ovary, Fallopian Tube and Peritoneum. J. Mind Med. Sci. 2021, 8, 44-52. https://doi.org/10.22543/7674.81.P4452
Georgescu T-A, Bohiltea R, Munteanu O, Grigoriu C, Paunica I, Sajin M. A Mini-Review Regarding the Carcinogenesis and Morphology of Serous Tumors of the Ovary, Fallopian Tube and Peritoneum. Journal of Mind and Medical Sciences. 2021; 8(1):44-52. https://doi.org/10.22543/7674.81.P4452
Chicago/Turabian StyleGeorgescu, Tiberiu-Augustin, Roxana Bohiltea, Octavian Munteanu, Corina Grigoriu, Ioana Paunica, and Maria Sajin. 2021. "A Mini-Review Regarding the Carcinogenesis and Morphology of Serous Tumors of the Ovary, Fallopian Tube and Peritoneum" Journal of Mind and Medical Sciences 8, no. 1: 44-52. https://doi.org/10.22543/7674.81.P4452
APA StyleGeorgescu, T.-A., Bohiltea, R., Munteanu, O., Grigoriu, C., Paunica, I., & Sajin, M. (2021). A Mini-Review Regarding the Carcinogenesis and Morphology of Serous Tumors of the Ovary, Fallopian Tube and Peritoneum. Journal of Mind and Medical Sciences, 8(1), 44-52. https://doi.org/10.22543/7674.81.P4452